US Patent No: 6,103,219

Number of patents in Portfolio can not be more than 2000

Pharmaceutical excipient having improved compressibility

1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0.1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
J. RETTENMAIER & SOEHNE GMBH + CO. KGROSENBERG30

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hunter, Edward A San Diego, CA 33 411
Sherwood, Bob E Amenia, NY 35 453
Staniforth, John H Bath, GB2 9 120

Cited Art

Patent Info (Count) # Cites Year
 
J. RETTENMAIER & SOEHNE GMBH + CO. KG (4)
5,585,115 Pharmaceutical excipient having improved compressability 54 1995
5,725,883 Pharmaceutical excipient having improved compressibility 34 1995
5,741,524 Sustained-release formulations utilizing pharmaceutical excipient having improved compressibility 52 1996
5,725,884 Pharmaceutical excipient having improved compressibility 27 1996
 
FMC CORPORATION (3)
4,744,987 Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation 84 1987
5,192,569 Fat-like bulking agent for aqueous foods comprising microcrystalline cellulose and a galactomannan gum 66 1991
5,441,753 Coprocessed particulate bulking and formulating AIDS: their composition, production, and use 38 1994
 
ALZA CORPORATION (2)
5,019,397 Aqueous emulsion for pharmaceutical dosage form 60 1988
4,946,685 Cellulosic dosage form 56 1988
 
BASF CORPORATION (1)
4,533,674 Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid 35 1983
 
BAYER AKTIENGESELLSCHAFT (1)
4,536,511 Medicaments containing muzolimine, their use and processes for their production 11 1984
 
BRISTOL-MYERS COMPANY (1)
4,664,915 Compressed and formed alkaline component suitable for use in buffered aspirin product 38 1986
 
MCNEIL-PPC, INC. (1)
5,462,747 Pharmaceutical sustained release matrix 62 1995
 
MERCK PATENT GMBH (1)
5,560,926 Process for the production of an S-ibuprofen-containing tablet 21 1994
 
SMITH KLINE & FRENCH LABORATORIES LIMITED (1)
5,441,731 Compounds 12 1992
 
SPB INC., 62% INTEREST (1)
4,923,981 Use of parenchymal cell cellulose to improve comestibles 40 1989
 
SUPERNUS PHARMACEUTICALS, INC (1)
5,447,729 Multilamellar drug delivery systems 42 1994
 
TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 96 1990
 
TEVA GYOGYSZERGYAR RESZVENYTARSASAG (1)
5,322,698 Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure 25 1992
 
THE PROCTER & GAMBLE COMPANY (1)
4,810,516 Reduced calorie and reduced fat chocolate confectionery compositions 61 1987
 
TOSHIBA CORPORATION (1)
4,303,846 Sintered electrode in a discharge tube 24 1980
 
WARNER-LAMBERT COMPANY (1)
4,910,023 Drug in combination with flavor masking agent and method for making same 32 1988
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (1)
4,721,709 Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions 47 1984

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
J. RETTENMAIER & SOEHNE GMBH + CO. KG (4)
6,358,533 Pharmaceutical excipient having improved compressibility 4 2001
6,866,867 Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose 4 2001
7,179,488 Process for co-spray drying liquid herbal extracts with dry silicified MCC 1 2002
6,746,693 Pharmaceutical excipient having improved compressibility 0 2002
 
DEPOMED, INC. (3)
8,377,453 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2009
8,372,432 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2009
8,394,408 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2012
 
DRUGTECH CORPORATION (2)
7,282,217 Rapidly disintegrable tablets 0 2004
7,425,341 Rapidly disintegrable tablets 1 2007
 
PFENEX, INC. (2)
7,267,963 Modified plant viruses and methods of use thereof 1 2000
7,666,624 Modified plant viruses and methods of use thereof 0 2007
 
SCHERING CORPORATION (2)
6,335,032 Orally administrable solid dosage form 2 2000
6,337,090 Orally administrable solid ribavirin dosage forms and process for making them 3 2000
 
EDWARD MENDELL & CO. (1)
6,660,303 Pharmaceutical superdisintegrant 4 2000
 
EVONIK DEGUSSA GMBH (1)
7,815,936 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions 6 2002
 
JRS PHARMA LP (1)
6,753,017 Process for preparing dry extracts 2 2001
 
WEI MING PHARMACEUTICAL MFG. CO., LTD. (1)
6,761,905 Process for the preparation of direct tabletting formulations and aids 0 2001
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (1)
8,445,018 Abuse resistant drug formulation 0 2008